Toward a Molecular Equivalent Dose: Use of the Medaka Model in Comparative Risk Assessment
Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology- United States
doi 10.1016/j.cbpc.2008.07.013
Full Text
Abstract
Available in
Categories
Date
March 1, 2009
Authors
Publisher
Elsevier BV